The Healthy Aging Company

DEVELOPING GAME CHANGER THERAPIES for
Diabetes Type 2 Diseases and its related complications such as Diabetic Neuropathy and Alzheimer's disease.

Leadership Team

An executive team with strong expertise in metabolism and diabetes, in clinical developments, as well as in biopharmaceutical business

Prof. Christian Bréchot, MD, PhD

Co-founder & Chairman of the Board

Prof. C. Bréchot is internationally renowned as the former head of French institutes (Pasteur institute, Inserm and Mérieux Institute). He is hepatologist, professor at the university of South Florida, and Chairman of the Global Virus Network.

Dr. Aurélie Joly-Amado, PHD

Scientific Consultant

Research scientist University of South Florida​
Consultant on neurodegenerative diseases​

Dr. Céline Cruciani-Guglielmacci, PhD

Scientific Consultant

Professor University Paris Cité​
Consultant on Metabolic syndrome and diabetes

Prof. Christophe Magnan, PhD

Director of the research laboratory

Prof. Christophe Magnan is a professor at the University of Paris Cité. An expert in glucose homeostasis, he is the author of more than 175 scientific articles. He heads the CNRS unit “Functional and Adaptive Biology” in Paris, with which THAC collaborates to carry out preclinical studies.

Dr. Gilles Amouyal, MD

Co-founder & Vice-President

Dr. Gilles Amouyal is an expert in hepato-gastro-enterology and former head of clinics. He is CSO of a biotech company and a Board Member of several biotech companies.

Dr. Paul Amouyal, MD

Co-founder & Vice-President

Dr. Paul Amouyal is an expert in hepato-gastro-enterology and former head of clinics. He is CEO of a biotech company and a board member of several biotech companies.

The CSIS is reporting to the President of the French Republics, to the Prime Minister as well as to the three Ministers for Industry, Health and Research.